News und Analysen
Die VOOPOO VINCI S ist da: 2000 mAh Leistung, 40 Watt maximale Leistung, atemberaubende Ästhetik
SHENZEN, China, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In einer Zeit, in der Funktionalität im Vordergrund steht, wird die Ästhetik oft übersehen. Die VOOPOO VINCI S stellt dies in Frage, indem sie ein
Puffco, weltweit führend in der Cannabiskonsum-Technologie, präsentiert die nächste Evolutionsstufe des Proxy-Vaporizers
Höhere Leistung, professionelle Personalisierung und ultimative Vielseitigkeit – weltweit erhältlich ab 16. September (Early Access) und 23. September (General Access)
LOS ANGELES, Sept. 17, 2025
If You'd Invested $10,000 in Wolfspeed 3 Years Ago, Here's How Much You'd Have Today
I used to own some Wolfspeed (NYSE: WOLF) stock, starting in March 2020, right after the COVID-19 crash. The company was known as Cree at the time, an experienced maker of LED light elements. Cree
A Once-in-a-Decade Investment Opportunity: 1 Vanguard Index Fund to Buy for the AI Boom
U.S. electricity demand stagnated during the past two decades because of the introduction of energy-efficient technologies like LED lightbulbs and modern appliances. Between 2005 and 2024
A Once-in-a-Decade Investment Opportunity: 1 Vanguard Index Fund to Buy for the AI Boom
Despite increased economic activity, U.S. electricity demand stagnated during the last two decades due to the introduction of energy-efficient technologies like LED lights and modern appliances
Methode EBITDA Jumps 60%
Methode Electronics (NYSE:MEI), a global manufacturer of mechatronic and electronic solutions serving the automotive, industrial, and interface markets, released its fiscal first quarter 2026
Tesla Started the Ball Rolling and It Could Mean a 9,000% Growth Driver for These 3 Dividend Stocks
Tesla (NASDAQ: TSLA) is a polarizing stock thanks partly to its larger-than-life CEO, Elon Musk. But Musk's theatrical flare literally helped to create the electric vehicle (EV) industry. Now, with
Health Canada genehmigt den Reveal®-Schnelltest von MedMira – ein dringend benötigtes neues Instrument im Kampf gegen Syphilis
Halifax, Nova Scotia, 26. August 2025 – MedMira Inc. (MedMira) (TSXV: MIR) gab heute bekannt, dass es von Health Canada die Zulassung für seinen Reveal® TP (Syphilis) Antikörpertest (Reveal®
Health Canada approves MedMira’s Reveal® Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
Halifax, Nova Scotia, 26 August 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody Test (Reveal®
MedMira kündigt Start der klinischen Studie für Multiplo® TP/HIV-Selbsttest in Kanada an
Halifax, Nova Scotia, 7. Juli 2025 - MedMira Inc. (MedMira) (TSXV: MIR) und REACH Nexus freuen sich, bekannt geben zu können, dass eine klinische Studie zur Evaluierung des Multiplo®
MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada
Halifax, Nova Scotia, July 7, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate